• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Seaport Calibre Materials Acquisition Corp. (Amendment)

    2/13/23 2:22:53 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous
    Get the next $SCMA alert in real time by email
    SC 13G/A 1 centiva-scma020123a2.htm



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*



     

    Seaport Calibre Materials Acquisition Corporation
    (Name of Issuer)

     

     

    Class A common stock, par value $0.0001 per share
    (Title of Class of Securities)

     

     

    812204105
    (CUSIP Number)

     

     

    February 1, 2023
    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    x Rule 13d-1(b)

    o Rule 13d-1(c)

    o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

     

    CUSIP No.  812204105
     SCHEDULE 13G/A
    Page 2 of 8 Pages
             
    1
    NAME OF REPORTING PERSONS
     
    Centiva Capital GP, LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    0
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    0
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.0%
    12
    TYPE OF REPORTING PERSON
     
    PN

     

     

    CUSIP No.  812204105
     SCHEDULE 13G/A
    Page 3 of 8 Pages
             
    1
    NAME OF REPORTING PERSONS
     
    Centiva Capital, LP
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    0
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    0
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.0%
    12
    TYPE OF REPORTING PERSON
     
    IA

     

     
     

     

    CUSIP No. 812204105
     SCHEDULE 13G/A
    Page 4 of 8 Pages

     

    Item 1.(a) Name of Issuer

    Seaport Calibre Materials Acquisition Corporation (the “Issuer”)

    (b) Address of Issuer’s Principal Executive Offices

    360 Madison Avenue, 20th Floor

    New York, NY 10017

    Item 2.(a) Name of Person Filing

    (1) Centiva Capital, LP (the "Investment Manager"), a Delaware limited partnership and the investment manager of certain affiliated funds (the "Centiva Capital Funds") with respect to the shares of Common Stock (as defined in Item 2(d); and

    (2) Centiva Capital GP, LLC, the general partner of the Investment Manager and the Centiva Capital Funds, with respect to the shares of Common Stock held by the Centiva Capital Funds.

     The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."

    The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock reported herein.

    (b) Address of Principal Business Office, or, if none, Residence

    55 Hudson Yards, Suite 22A

    New York, NY 10001

    (c) Citizenship

    Centiva Capital GP, LLC – Delaware

    Centiva Capital, LP – Delaware

     (d) Title of Class of Securities

    Class A common stock, par value $0.0001 per share (the “Common Stock”)

     (e) CUSIP No.:

    812204105

     
     

     

    CUSIP No. 812204105
     SCHEDULE 13G/A
    Page 5 of 8 Pages

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
      (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
      (g) o A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
      (k) ¨ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                            
           

     

     
     

     

    CUSIP No.  812204105
     SCHEDULE 13G/A
    Page 6 of 8 Pages

     

     

    Item 4. Ownership

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a) Amount beneficially owned:

    Centiva Capital GP, LLC. – 0

    Centiva Capital, LP – 0

    (b) Percent of class:

    0% of the 0 shares of Common Stock (Class A) outstanding as of February 1, 2023 as reported in the Issuer’s Form 10-Q Quarterly Report filed on November 14, 2022.

    (c) Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote:

    Centiva Capital GP, LLC. – 0

    Centiva Capital, LP – 0

    (ii) Shared power to vote or to direct the vote:

    Centiva Capital GP, LLC. – 0

    Centiva Capital, LP – 0

    (iii) Sole power to dispose or to direct the disposition of:

    Centiva Capital GP, LLC. – 0

    Centiva Capital, LP – 0

    (iv) Shared power to dispose or to direct the disposition of:

    Centiva Capital GP, LLC. – 0

    Centiva Capital, LP – 0

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

    Item 5. Ownership of Five Percent or Less of a Class

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

     

    Not Applicable

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

     

    Not Applicable

    Item 8. Identification and Classification of Members of the Group

     

    Not Applicable

    Item 9. Notice of Dissolution of Group

     

    Not Applicable

    Item 10. Certification

     

    By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     
     
    CUSIP No.  812204105
     SCHEDULE 13G/A
    Page 7 of 8 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 13, 2023

     

     

      Centiva Capital, LP
           
      By:  /s/ James Murray
        Name:  James Murray
        Title:  Chief Compliance Officer

     

     

     

     

     

     

     

     
    CUSIP No. 812204105
     SCHEDULE 13G/A
    Page 8 of 8 Pages

     

    Exhibit I

     

    JOINT FILING STATEMENT

     

    PURSUANT TO RULE 13d-1(k)

     

    The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Dated: February 13, 2023

     

     

    Centiva Capital GP, LLC

           
      By:  /s/ James Murray
       

    Name: James Murray

    Title: Chief Compliance Officer

           

    Get the next $SCMA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SCMA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SCMA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Seaport Calibre Materials Acquisition Corp. Announces It Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination

    NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Seaport Calibre Materials Acquisition Corp. (NASDAQ:SCMA) (the "Company") announced today that, because the Company will not consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (the "Amended Charter"), the Company intends to dissolve and liquidate in accordance with the provisions of the Amended Charter, effective as of the close of business on February 1, 2023. On January 13, 2023, the Company filed with the Securities and Exchange Commission a definitive proxy statement (the "Proxy Statement") in connection with a special meeting of stockholders to consider and vot

    2/1/23 9:00:00 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    Seaport Calibre Materials Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders

    NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Seaport Calibre Materials Acquisition Corp. (Nasdaq: SCMA) (the "Company") announced today that it has postponed the Company's Special Meeting of Stockholders to be held on January 26, 2023, until January 31, 2023, at 1:00 p.m. Eastern Time. The postponed Special Meeting will be completely virtual and stockholders will be able to attend the special meeting online, vote and submit questions by visiting https://www.cstproxy.com/seaportcalibreacquisition/2023. There will be no change in the record date as a result of this postponement, and proxies tendered prior to the postponed date will not need to be voted again. Stockholders may elect to redeem

    1/26/23 5:00:00 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    $SCMA
    SEC Filings

    View All

    SEC Form 15-12G filed by Seaport Calibre Materials Acquisition Corp.

    15-12G - Seaport Calibre Materials Acquisition Corp. (0001863428) (Filer)

    2/13/23 4:33:20 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form 25-NSE filed by Seaport Calibre Materials Acquisition Corp.

    25-NSE - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/2/23 4:15:02 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    Seaport Calibre Materials Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Seaport Calibre Materials Acquisition Corp. (0001863428) (Filer)

    2/1/23 9:10:38 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    $SCMA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Barclays Plc

    4 - Seaport Calibre Materials Acquisition Corp. (0001863428) (Issuer)

    8/26/22 1:50:25 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form 3: New insider Barclays Plc claimed ownership of 1,481,560 shares

    3 - Seaport Calibre Materials Acquisition Corp. (0001863428) (Issuer)

    8/26/22 10:39:08 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    $SCMA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Seaport Calibre Materials Acquisition Corp. (Amendment)

    SC 13G/A - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/14/24 1:28:06 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form SC 13G/A filed by Seaport Calibre Materials Acquisition Corp. (Amendment)

    SC 13G/A - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/9/24 11:04:13 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form SC 13G/A filed by Seaport Calibre Materials Acquisition Corp. (Amendment)

    SC 13G/A - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/14/23 3:30:17 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous